ORLANDO, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 17.848
AS - Asia 8.230
EU - Europa 7.899
SA - Sud America 1.045
Continente sconosciuto - Info sul continente non disponibili 248
AF - Africa 226
OC - Oceania 23
Totale 35.519
Nazione #
US - Stati Uniti d'America 17.392
GB - Regno Unito 2.785
SG - Singapore 2.511
CN - Cina 2.055
IT - Italia 1.512
HK - Hong Kong 916
VN - Vietnam 883
SE - Svezia 845
BR - Brasile 758
DE - Germania 688
BD - Bangladesh 408
FI - Finlandia 403
RU - Federazione Russa 352
FR - Francia 348
TR - Turchia 323
UA - Ucraina 309
CA - Canada 278
IN - India 241
KR - Corea 218
BG - Bulgaria 138
ID - Indonesia 128
NL - Olanda 96
MX - Messico 92
ZA - Sudafrica 85
AR - Argentina 78
IQ - Iraq 75
JP - Giappone 62
ES - Italia 56
PK - Pakistan 54
PL - Polonia 52
CO - Colombia 51
LT - Lituania 46
AE - Emirati Arabi Uniti 42
CL - Cile 40
EC - Ecuador 35
IR - Iran 35
MA - Marocco 35
BE - Belgio 33
IE - Irlanda 33
CZ - Repubblica Ceca 32
MY - Malesia 29
IL - Israele 27
UZ - Uzbekistan 26
VE - Venezuela 26
TH - Thailandia 24
NP - Nepal 22
PH - Filippine 22
CR - Costa Rica 21
JO - Giordania 21
PY - Paraguay 21
AU - Australia 20
PE - Perù 20
SA - Arabia Saudita 20
AT - Austria 19
RO - Romania 18
JM - Giamaica 16
KE - Kenya 16
EU - Europa 15
NG - Nigeria 15
SI - Slovenia 15
EG - Egitto 14
KZ - Kazakistan 14
DZ - Algeria 13
MD - Moldavia 12
AL - Albania 10
GE - Georgia 10
DK - Danimarca 9
GR - Grecia 9
SN - Senegal 9
TN - Tunisia 9
BY - Bielorussia 8
CH - Svizzera 8
HU - Ungheria 8
SV - El Salvador 8
UY - Uruguay 8
AZ - Azerbaigian 7
LV - Lettonia 7
NI - Nicaragua 7
NO - Norvegia 7
PT - Portogallo 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
PR - Porto Rico 6
QA - Qatar 6
TW - Taiwan 6
CI - Costa d'Avorio 5
EE - Estonia 5
ET - Etiopia 5
HN - Honduras 5
HR - Croazia 5
KG - Kirghizistan 5
OM - Oman 5
PA - Panama 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
KH - Cambogia 3
Totale 35.222
Città #
Southend 2.192
Ashburn 1.759
Santa Clara 1.673
Singapore 1.571
Fairfield 1.214
Chandler 1.059
Hong Kong 902
Woodbridge 854
San Jose 765
Houston 626
Jacksonville 531
Beijing 499
Dearborn 487
Nyköping 468
Wilmington 468
Seattle 457
Council Bluffs 439
Hefei 428
Cambridge 406
Los Angeles 358
Chicago 355
Ann Arbor 335
London 327
Dallas 297
Ho Chi Minh City 291
New York 254
The Dalles 247
Helsinki 239
Modena 225
Seoul 189
Hanoi 180
Izmir 178
San Diego 145
Princeton 143
Munich 142
Shanghai 136
Salt Lake City 132
Sofia 127
Milan 124
Lauterbourg 112
Buffalo 110
Eugene 104
Bremen 101
Bologna 86
Moscow 81
Toronto 81
Frankfurt am Main 80
Tampa 80
Jakarta 78
Columbus 72
Rome 68
São Paulo 66
Orem 60
Turku 56
Johannesburg 55
Mumbai 55
Elk Grove Village 54
Atlanta 49
Redwood City 49
Tokyo 49
Montreal 46
Fremont 43
Des Moines 42
Phoenix 41
Warsaw 41
Da Nang 39
Boardman 37
Chennai 37
Falls Church 37
North York 37
Sterling 37
Amsterdam 35
Haiphong 33
Mexico City 32
Detroit 31
Naples 31
Rio de Janeiro 31
Brooklyn 30
Stockholm 30
Baghdad 29
Brussels 29
Dublin 28
Guangzhou 28
Parma 28
Lancaster 26
Dong Ket 25
Denver 24
Miami 24
Biên Hòa 23
Tashkent 23
Norwalk 21
Belo Horizonte 20
Nanjing 20
Paris 20
Poplar 20
Turin 20
Brno 19
Augusta 18
Boston 18
Changsha 18
Totale 23.939
Nome #
Hypertriglyceridemia and Waist Circumference Predict Cardiovascular Risk among HIV Patients: A Cross-Sectional Study 745
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 523
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 491
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 479
Human immunodeficiency virus infection is associated with accelerated atherosclerosis. 472
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 469
Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV 447
Premature age-related comorbidities among HIV-infected persons compared with the general population 438
Nonalcoholic Fatty Liver Disease in HIV-Infected Patients Referred to a Metabolic Clinic: Prevalence, Characteristics, and Predictors 428
GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls 413
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 400
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 383
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 381
Inverse correlation between vascular calcification and bone mineral density in human immunodeficiency virus-infected patients 379
Erectile Dysfunction Is Not a Mirror of Endothelial Dysfunction in HIV-Infected Patients. 378
High-density hyaluronic acid for the treatment of HIV-related facial lipoatrophy 376
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 375
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 367
Ectopic fat is linked to prior cardiovascular events in men with HIV. 352
Long-term efficacy and safety of polyacrylamide hydrogel injection in the treatment of human immunodeficiency virus-related facial lipoatrophy: a 5-year follow-up. 352
Cost of noninfectious comorbidities in patients with HIV 349
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature 346
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 341
Hypokalemia in Patients with COVID-19 334
Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study 328
Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. 326
Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. 325
Independent association of subclinical coronary artery disease and emphysema in HIV-infected patients 324
Abstract: P784 ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 321
Upregulation of nuclear-encoded mitochondrial LON protease in HAART-treated HIV-positive patients with lipodystrophy: implications for the pathogenesis of the disease 320
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women 317
Re: Lebentrau S, Gilfrich C, Vetterlein MW, Schumacher H, Spachmann PJ, Brookman-May SD, Fritsche HM, Schostak M, Wagenlehner F, Burger M, May M, MR2 study group (2017) Impact of the medical specialty on knowledge regarding multidrug-resistant organisms and strategies toward antimicrobial stewardship. Int Urol Nephrol 49:1311–1318 316
The natural history of HIV-associated lipodystrophy in the changing scenario of HIV infection 312
Body image is a major determinant of sexual dysfunction in stable HIV-infected women. 308
Peritoneal dialysis in the time of coronavirus disease 2019 308
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 300
Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. 298
Body Composition changes in ageing HIV infected patients: the complex interplay between low muscle mass, lipodystrophy and osteopenia. 298
Combined Use of Waist and Hip Circumference to Identify Abdominally Obese HIV-Infected Patients at Increased Health Risk 297
Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. 293
Surgical correction of HIV-associated facial lipoatrophy. 292
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 289
Altered mitochondrial RNA production in adipocytes from HIV-infected individuals with lipodystrophy 288
Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: Monarch randomized controlled trial 285
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 284
Premature Decline of Serum Total Testosterone in HIV-Infected Men in the HAART-Era 284
Associatioin of epicardial adipose tissue with incident coronary heart disease and death in HIV infected patients. 284
A randomized, controlled trial to evaluate change in cardiometabolic and endothelial function in HIV-infected patients with optimal viral suppression on Darunavir/ritonavir monotherapy vs. triple-therapy. 278
Tenofovir accelerates bone mass loss of the lumbar spine in the first years of menopause in HIV infected women. 278
Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution 276
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 273
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 270
Antiretroviral drugs induced metabolic diseases in HIV infected patients. 267
Significant chronic airway abnormalities in never-smoking HIV-infected patients 267
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 267
Erectile dysfunction does not mirror endothelial dysfunction in hiv-infected patients 264
Combined use of waist and thigh circumference to identify high-risk,, abdominally obese HIV+ patients. 264
Glomerular filtration rates in HIV-infected patients treated with and without tenofovir: a prospective, observational study. 263
Prevalence and characterization of hypogonadism among men with human immunodeficiency virus infection: preliminary results 259
CD4 nadir and antiretroviral exposure predict premature polypathology onset 258
Body Image is a major determinant of sexual dysfunction in stable HIV-infected women. 258
ANTIRETROVIRAL THERAPY AND LIPODYSTROPHY AS PREDICTORS OF SUB-CLINICAL ATHEROSCLEROSIS 257
Cost of non-infectious co-morbidities in patients with HIV 254
Abacavir and Tenofovir impact on endothelial. 254
Subclinical coronary artery atherosclerosis and endothelial dysfunction are not predictors of erectile dysfunction in HIV-infected males 254
Coronary artery calcification is associated with femoral but not with lumbar spine mineral density 250
Dietary evaluation and metabolic alterations in HIV-related lipodystrophy 247
Assessment of 10-year probability of a major osteoporotic fracture in HIV-infected patients using FRAX® tool algorithms. 247
Association of serum vitamin D levels nd type 2 diabetes in HIV infection in the Modena cohort 247
Bone mineral density and sex hormones in HIV-infected men 247
Vitamin D3 supplementation decreases the risk of diabetes mellitus among patients with HIV infection. 246
Prevalence of secondary causes of osteoporosis among HIV infected individuals 244
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 243
Hypopituitarism and HIV-infection: a new comorbidity in the HAART era? 243
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program 243
Randomized Trial to Evaluate Cardiometabolic and Endothelial Function in Patients with Plasma HIV-1 RNA Suppression Switching to Darunavir/Ritonavir with or without Nucleoside Analogues 235
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 235
Impairment of GH response to GHRH+Arginine in women affected by HIV-related adipose tissue redistribution syndrome (HARS) 232
Testosterone Changes over Time in Men with Human Immunodeficiency Virus Infection: Preliminary Results 231
Testosterone changes over time in men with human immunodeficiency virus infection: preliminary results 230
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 229
Emphysema is an independent predictor of coronary artery calcium score in a large cohort of HIV infected patients 229
Effectiveness and long-term durability of autologous fat transplant for HIV-related face lipoatrophy. 226
Central Nervous System Infections Caused by Bacillus Calmette-Guerin: Case Report and Narrative Literature Review 223
Emphysema is an independent predictor of coronary artery calcium score in a large cohort of HIV-infected patients. 223
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 220
Sensitivity and specificity of visceral and epicardial adipose tissue values in the prediction of occult cardiovascular disease in HIV-infected patients. 220
CORONARY AGEING IN HIV INFECTED PATIENTS 215
Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study. 215
Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (Xdr) and multidrug-resistant (mdr) pseudomonas aeruginosa: Resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs 214
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 214
Determinants of erectile dysfunction changes in HIV infected men: a prospective study. 213
Erectile Dysfunction Does Not Mirror Endothelial Dysfunction in HIV-Infected Patients 212
Gender and gonadal function differences in the prevalence of bone mass reduction 212
Impaired GH secretion in women with HIV-related lipodystrophy 211
Coronary artery calcification is associated with femoral but not with lumbar spine mineral density 210
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 209
Prevalence and characterization of hypogonadism among men with human immunodeficiency virus infection: preliminary results. 206
Impaired GH secretion in women with HIV-related lipodystrophy 205
EAT volume is an independent risk factor of cardiovascular disease in HIV-infected patients 204
Totale 29.706
Categoria #
all - tutte 134.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.025


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.496 0 361 144 182 123 149 186 138 245 191 416 361
2022/20232.889 324 343 250 286 350 428 59 265 341 31 101 111
2023/20241.995 60 113 115 217 385 277 151 186 53 85 125 228
2024/20255.799 138 98 112 428 1.143 856 431 310 735 233 584 731
2025/202611.613 663 402 920 1.364 2.326 658 1.382 487 1.083 1.120 736 472
2026/20271.215 282 933 0 0 0 0 0 0 0 0 0 0
Totale 35.519